Embolic stroke of undetermined source and atrial cardiopathy: Towards a personalized antithrombotic strategy for secondary stroke prevention

dc.creator	Ntaios G., Korompoki E.	en
dc.date.accessioned	2023-01-31T09:40:32Z
dc.date.available	2023-01-31T09:40:32Z
dc.date.issued	2022
dc.identifier	10.1016/j.ejim.2022.02.016
dc.identifier.issn	09536205
dc.identifier.uri	http://hdl.handle.net/11615/77275
dc.description.abstract	[No abstract available]	en
dc.language.iso	en	en
dc.source	European Journal of Internal Medicine	en
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124911139&doi=10.1016%2fj.ejim.2022.02.016&partnerID=40&md5=cc0c171007059a3055b0d5eaa4a22c3f
dc.subject	fibrinolytic agent	en
dc.subject	cerebrovascular accident	en
dc.subject	complication	en
dc.subject	heart disease	en
dc.subject	human	en
dc.subject	secondary prevention	en
dc.subject	Embolic Stroke	en
dc.subject	Fibrinolytic Agents	en
dc.subject	Heart Diseases	en
dc.subject	Humans	en
dc.subject	Secondary Prevention	en
dc.subject	Stroke	en
dc.subject	Elsevier B.V.	en
dc.title	Embolic stroke of undetermined source and atrial cardiopathy: Towards a personalized antithrombotic strategy for secondary stroke prevention	en
dc.type	other	en

Files in this item

Files	Size	Format	View
There are no files associated with this item.